Diurnal variation of folate concentrations in mouse embryo and plasma: the protective effect of folinic acid on valproic-acid-induced teratogenicity is time dependent
- PMID: 1810574
- DOI: 10.1016/0890-6238(91)90017-a
Diurnal variation of folate concentrations in mouse embryo and plasma: the protective effect of folinic acid on valproic-acid-induced teratogenicity is time dependent
Abstract
The diurnal variation of folate concentrations in mouse plasma and embryo between day 8.5 and day 9.5 of gestation (light cycle = 0900-2100) were determined by high-performance liquid chromatography. Folate concentrations in the embryo were high during the evening hours, decreased during the night, reached their lowest levels at 0500, and then increased again during the day. High levels of folates may be related to increased food intake by the pregnant mice. Small changes of the two major maternal plasma folate metabolites were observed. The relative amount of each folate metabolite in the embryo, as compared to the total folate concentration, remained in a narrow range. The main metabolites were tetrahydrofolic acid (THF) (32.4% +/- 2.1% of total folates), 5-CHO-THF (24.2% +/- 2.3%), and 10-CHO-THF (17.0% +/- 1.9%). A dramatic alteration of these ratios occurred only between 1100 and 1400. The relative content of THF increased (52.7% +/- 2.5%), whereas the relative concentration of 5-CHO-THF in the embryo decreased (6.5% +/- 1.9%). Before 1000 when the ratios of folate metabolites were stable, the rate of valproic acid-induced neural tube defects was reduced from 49% of living fetuses to 12% by coapplication of folinic acid via subcutaneously implanted minipumps. During the period in which dramatic changes in ratios between the folate metabolites in the embryo occurred, no protective effect of folinic acid on valproic acid-induced exencephaly could be observed. Our results indicate that the diurnal variation of folate metabolism in the embryo is important in regard to valproic acid teratogenesis and its protection by folate supplementation.
Similar articles
-
Valproic acid-induced neural tube defects: reduction by folinic acid in the mouse.Life Sci. 1987 Jul 6;41(1):103-10. doi: 10.1016/0024-3205(87)90562-5. Life Sci. 1987. PMID: 3110521
-
Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis.Neurology. 1992 Apr;42(4 Suppl 5):17-24. Neurology. 1992. PMID: 1574172
-
Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice.Fundam Appl Toxicol. 1992 Apr;18(3):389-94. doi: 10.1016/0272-0590(92)90137-7. Fundam Appl Toxicol. 1992. PMID: 1597263
-
Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.Pharmacol Toxicol. 1991 Nov;69(5):310-21. doi: 10.1111/j.1600-0773.1991.tb01303.x. Pharmacol Toxicol. 1991. PMID: 1803343 Review.
-
Valproic acid-induced neural tube defects.Ciba Found Symp. 1994;181:144-52; discussion 152-60. doi: 10.1002/9780470514559.ch9. Ciba Found Symp. 1994. PMID: 8005022 Review.
Cited by
-
Differentiation between valproate-induced anticonvulsant effect, teratogenicity and hepatotoxicity. Aspects of species variation, pharmacokinetics, metabolism and implications of structural specificity for the development of alternative antiepileptic agents such as delta 2-valproate.Pharm Weekbl Sci. 1992 Jun 19;14(3A):101-7. doi: 10.1007/BF01962697. Pharm Weekbl Sci. 1992. PMID: 1502007 Review.
-
Animal models of autism: an epigenetic and environmental viewpoint.J Cent Nerv Syst Dis. 2010 Nov 10;2:37-44. doi: 10.4137/JCNSD.S6188. Print 2010. J Cent Nerv Syst Dis. 2010. PMID: 23861630 Free PMC article.
-
Ascorbic acid reverses valproic acid-induced inhibition of hoxa2 and maintains glutathione homeostasis in mouse embryos in culture.Cell Mol Neurobiol. 2010 Jan;30(1):137-48. doi: 10.1007/s10571-009-9438-7. Epub 2009 Aug 5. Cell Mol Neurobiol. 2010. PMID: 19655241 Free PMC article.
-
Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.Anat Rec A Discov Mol Cell Evol Biol. 2006 Dec;288(12):1303-9. doi: 10.1002/ar.a.20397. Anat Rec A Discov Mol Cell Evol Biol. 2006. PMID: 17075842 Free PMC article.
-
Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations.Environ Health Perspect. 2001 Mar;109 Suppl 1(Suppl 1):101-11. doi: 10.1289/ehp.01109s1101. Environ Health Perspect. 2001. PMID: 11250810 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical